期刊文献+

喹诺酮类化合物的合成、体外抗肿瘤活性与分子对接研究

Synthesis,Antitumor Activity and Molecular Docking of Quinolone Derivatives
原文传递
导出
摘要 目的研究新型喹诺酮类衍生物的合成方法及抗肿瘤活性。方法以环丙沙星结构为基础,采用基于片段的药物设计方法合成目标化合物,以MTT法测试目标化合物对A549、HL-60、Hela等肿瘤细胞的抑制活性。并运用Discovery Studio软件的Libdock模块对目标化合物进行分子对接研究。结果合成了8个新的目标化合物,体外均显示潜在的抗肿瘤活性。结论该类喹诺酮类衍生物的抗肿瘤活性值得进一步研究。 OBJECTIVE To study the synthesis and antitumor activity of novel quinolone derivatives. METHODS Based on the structure of ciprofloxacin, the objective substances were designed and synthesized according to the principle of fragment- based drug discovery. Their anti-tumor activities in vitro were evaluated against A549, HL-60, and Hela cells by MTT assay. Molecular docking studies were performed with the Libdock protocol of Discovery Studio to afford the ideal interaction mode of the compound with the binding site of the Topo I . RESULTS Eight novel compounds were synthesized and showed potential an- titumor activities. CONCLUSION The antitumor activities of the synthesized quinolone derivatives are worthy of further study.
出处 《中国药学杂志》 CAS CSCD 北大核心 2016年第22期1913-1917,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(21306104 21476128) 浙江省教育厅科研项目(Y201329284)
关键词 喹诺酮类化合物 抗肿瘤活性 分子对接 TOPO I抑制剂 quinolone derivatives antitumor activity molecular docking Topo I inhibitor
  • 相关文献

参考文献5

二级参考文献16

  • 1胡国强,谢松强,许秋菊,黄文龙,张惠斌,黄胜堂.3-(5-取代苯基-[1,3,4]恶二唑-2-亚甲硫基)-5-吡啶-3-基-[1,2,4]三唑-4-胺的合成及抗菌活性[J].药学学报,2005,40(4):337-339. 被引量:16
  • 2ABDEL-AZIZ M, BESHR E A, ABDEL-RAHMAN I M, et al. 1 -(4-Methoxyphenyl ) -5-( 3,4,5-trimethoxy-phenyl ) -1H-1,2,4- triazole-3-carboxamides : synthesis, molecular modeling, evalua- tion of their anti-inflammatory activity and ulcerogenicity [J]. Eur J Med Chem, 2014, 77 : 155-165.
  • 3SAHU J K, GANGULY S, KAUSHIK A. Triazoles:A valuable insight into recent developments and biological activities [ J ]. Chin J Nat Med, 2013, 11(5) :456-465.
  • 4KONSTANTINOVA I D, CHUDINOV M V, FATEEV I V, et al. Nucleosides of 1,2,4-triazole : Potentialities and restrictions of chemo-enzymatic method for synthesis [J]. Bioorg Khim, 2013, 39(1) :61-80.
  • 5ZHANG F, WEN Q, WANG S F, et al. Design, synthesis and antibacterial activities of 5-( pyrazin-2-yl ) -411-1,2,4-triazole-3- thiol derivatives containing Schiff base formation as FabH inhibitory [J]. Bioorg Med Chem Lett, 2014, 24( 1 ) :90-95.
  • 6SHI Y J, SONG X J, LI X, et al. Synthesis and biological evalu- ation of 1,2,4-triazole and 1,3,4-thiadiazole derivatives as po- tential cytotoxie agents [ J]. Chem Pharm Bull(Tokyo), 2013, 61 ( 11 ) :1099-1104.
  • 7KATSRRA Y, NISHINO S, INOUE Y, et al. Anti-helicobacter priori agents. 5. 2-(substituted guanidino)4-arylthiazoles and aryloxazole analogues [J]. J Med Chem, 2002, 45 ( 1 ): 143- 150.
  • 8ALTINTOP M D, ZDEMIR A, TURAN-ZITOUNI G, et al. Syn- thesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents [ J ]. Eur J Med Chem, 2012, 58( 1 ) :299-307.
  • 9郭宗儒.药物分子设计的策略:论药效团和骨架迁越[J].中国药物化学杂志,2008,18(2):147-157. 被引量:16
  • 10季宇彬,周建华,左明新,尤启冬.新型TopoⅠ抑制剂CPUY013对胃腺癌细胞BGC823的体内外作用[J].药学学报,2008,43(8):811-818. 被引量:5

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部